ArticleCureus2026

Targeting Cellulite as a Metabolic-Dermal Interface: Effects of Tirzepatide and a Multi-Pathway Topical Therapy (G21) in a 12-Month Observational Study.

Nikos Adamidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.